Repository logo
Communities & Collections
All of DSpace
  • English
  • العربية
  • বাংলা
  • Català
  • Čeština
  • Deutsch
  • Ελληνικά
  • Español
  • Suomi
  • Français
  • Gàidhlig
  • हिंदी
  • Magyar
  • Italiano
  • Қазақ
  • Latviešu
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Српски
  • Svenska
  • Türkçe
  • Yкраї́нська
  • Tiếng Việt
Log In
New user? Click here to register. Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Verdugo Parra, John Esteban"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Item
    Nasoangiofibroma juvenil - reporte de caso clínico y revisión literaria
    (Universidad de Cuenca, 2024-09-13) Verdugo Parra, John Esteban; Orellana Barros, Kevin Fabricio; Guamán Roldan, Hugo Xavier
    Juvenile nasoangiofibroma is a benign tumor with locally aggressive behavior, given the significant epistaxis it causes, frequent complications, and therapeutic complexity presented by this condition, diagnosis and treatment should be thorough; it occurs exclusively in adolescent males and accounts for 0.5%-0.05% of all head and neck tumors. This case corresponds to an 18-year-old patient with progressive respiratory difficulty over 2 years, nasal obstruction, and epistaxis. Clinical and imaging studies revealed a diagnosis of juvenile nasoangiofibroma at stage IIb according to Radkowski's classification. A Degloving approach was performed, and the tumor was completely removed. One year after resection, no tumor recurrence has been recorded. Conclusion: Juvenile nasoangiofibroma predominantly affects adolescent males and is primarily characterized by recurrent episodes of epistaxis. Surgical management remains the cornerstone of treatment, with various effective approaches available. The local recurrence rate is low, underscoring the effectiveness of current interventions in most cases.

DSpace software copyright © 2002-2025 LYRASIS

  • Privacy policy
  • End User Agreement
  • Send Feedback